Universal Ibogaine Inc (IBO.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 07/31
| 10-2022 | 07-2022 | 04-2022 | 01-2022 | 10-2021 | |
| Sales | 0 | 131 | 369 | 433 | 137 |
| Cost of Goods | N/A | N/A | N/A | N/A | 68 |
| Gross Profit | N/A | N/A | N/A | N/A | 70 |
| Operating Expenses | 795 | 1,203 | 1,514 | 1,427 | 1,605 |
| Operating Income | -795 | -1,072 | -1,145 | -994 | -1,535 |
| Interest Expense | 47 | 12 | 10 | 22 | 24 |
| Other Income | 0 | -5,468 | -18 | -24 | -172 |
| Pre-tax Income | -842 | -6,552 | -1,174 | -1,040 | -1,731 |
| Net Income Continuous | -842 | -6,552 | -1,174 | -1,040 | -1,731 |
| Net Income | $-842 | $-6,552 | $-1,174 | $-1,040 | $-1,731 |
| EPS Basic Total Ops | 0.00 | -0.04 | -0.01 | -0.01 | -0.01 |
| EPS Basic Continuous Ops | 0.00 | -0.04 | -0.01 | -0.01 | -0.01 |
| EPS Diluted Total Ops | 0.00 | -0.04 | -0.01 | -0.01 | -0.01 |
| EPS Diluted Continuous Ops | 0.00 | -0.04 | -0.01 | -0.01 | -0.01 |
| EBITDA(a) | $-729 | $-6,460 | $-1,092 | $-949 | $-1,661 |